KLF5 and colorectal cancer: In addition, studies have shown that knockdown of KLF5 could reduce cellular resistance to adriamycin in mesenchymal thyroid cancer, while high expression of KLF5 in colorectal cancer predicted poorer neoadjuvant chemotherapy outcomes26.